These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 36176915)

  • 21. Green Tea and Epigallocatechin Gallate (EGCG) for the Management of Nonalcoholic Fatty Liver Diseases (NAFLD): Insights into the Role of Oxidative Stress and Antioxidant Mechanism.
    Tang G; Xu Y; Zhang C; Wang N; Li H; Feng Y
    Antioxidants (Basel); 2021 Jul; 10(7):. PubMed ID: 34356308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds.
    Pan MH; Lai CS; Tsai ML; Ho CT
    Mol Nutr Food Res; 2014 Jan; 58(1):147-71. PubMed ID: 24302567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease.
    Wang J; He W; Tsai PJ; Chen PH; Ye M; Guo J; Su Z
    Lipids Health Dis; 2020 Apr; 19(1):72. PubMed ID: 32284046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Explore the Mechanism of Astragalus mongholicus Bunge against Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Experimental Verification.
    Fu L; Wu Z; Chu Y; Chen W; Gao L; Mu S; Zhao J
    Gastroenterol Res Pract; 2022; 2022():4745042. PubMed ID: 35422858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Jiang-Zhi granules decrease sensitivity to low-dose CCl
    Yang L; Zhou Y; Song H; Zheng P
    BMC Complement Altern Med; 2019 Aug; 19(1):228. PubMed ID: 31438932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery.
    Zhang ND; Han T; Huang BK; Rahman K; Jiang YP; Xu HT; Qin LP; Xin HL; Zhang QY; Li YM
    J Ethnopharmacol; 2016 Aug; 189():61-80. PubMed ID: 27180315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory Effects and Molecular Mechanisms of Tea and Its Active Compounds on Nonalcoholic Fatty Liver Disease.
    Xu J; Wei Y; Huang Y; Wei X
    J Agric Food Chem; 2023 Feb; ():. PubMed ID: 36773311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease.
    Perla FM; Prelati M; Lavorato M; Visicchio D; Anania C
    Children (Basel); 2017 Jun; 4(6):. PubMed ID: 28587303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect of traditional Chinese medicine on non-alcoholic fatty liver disease and liver cancer by targeting ferroptosis.
    Wu Q; Chen Z; Ding Y; Tang Y; Cheng Y
    Front Nutr; 2022; 9():1033129. PubMed ID: 36330148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease.
    Chen Z; Tian R; She Z; Cai J; Li H
    Free Radic Biol Med; 2020 May; 152():116-141. PubMed ID: 32156524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PDB-1 from Potentilla discolor Bunge induces apoptosis and autophagy by downregulating the PI3K/Akt/mTOR signaling pathway in A549 cells.
    Zhang RR; Meng NN; Liu C; Li KL; Wang MX; Lv ZB; Chen SY; Guo X; Wang XK; Wang Q; Sun JY
    Biomed Pharmacother; 2020 Sep; 129():110378. PubMed ID: 32544818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions.
    Ore A; Akinloye OA
    Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Shi KQ; Fan YC; Liu WY; Li LF; Chen YP; Zheng MH
    Mol Biol Rep; 2012 Oct; 39(10):9715-22. PubMed ID: 22718512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease.
    Eslamparast T; Eghtesad S; Poustchi H; Hekmatdoost A
    World J Hepatol; 2015 Feb; 7(2):204-12. PubMed ID: 25729475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Sugimoto K; Inui H; Fukusato T
    World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway.
    Chen M; Xing J; Pan D; Peng X; Gao P
    Biomed Pharmacother; 2020 Aug; 128():110286. PubMed ID: 32521450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice.
    Kant R; Lu CK; Nguyen HM; Hsiao HH; Chen CJ; Hsiao HP; Lin KJ; Fang CC; Yen CH
    Biomed Pharmacother; 2020 Sep; 129():110348. PubMed ID: 32554245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural Active Compounds from Plant Food and Chinese Herbal Medicine for Nonalcoholic Fatty Liver Disease.
    Liu Q; Zhu L; Cheng C; Hu YY; Feng Q
    Curr Pharm Des; 2017; 23(34):5136-5162. PubMed ID: 28925892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herbal drug discovery for the treatment of nonalcoholic fatty liver disease.
    Yan T; Yan N; Wang P; Xia Y; Hao H; Wang G; Gonzalez FJ
    Acta Pharm Sin B; 2020 Jan; 10(1):3-18. PubMed ID: 31993304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
    Liu X; Chen S; Zhang L
    Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.